Kroenke, Kurt MD*; Spitzer, Robert L. MD†; Williams, Janet B. W. DSW†
From the *Regenstrief Institute for Health Care and Department of Medicine, Indiana University, Indianapolis, Indiana.
From the †New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York, NY.
The development of the PHQ-2 was underwritten by an educational grant from Pfizer US Pharmaceuticals Inc., New York, NY. PRIME-MD is a trademark of Pfizer Inc. Copyright held by Pfizer Inc.
Address correspondence and reprint requests to: Kurt Kroenke, MD, Regenstrief Institute for Health Care, RG-6, 1050 Wishard Blvd., Indianapolis, IN 46202. E-mail: [email protected]
For a complimentary copy of PHQ materials that can be reproduced, e-mail Robert Spitzer at [email protected]